WELL Health
Trending >

The Hydropothecary Corporation is undervalued, says Canaccord Genuity


HydropothecaryThe only Licensed Producer in Quebec is a buy right now, says Canaccord Genuity analyst Matt Bottomley.

In a research report to clients today, Bottomley inititiated coverage of The Hydropothecary Corporation (The Hydropothecary Corporation Stock Quote, Chart, News: TSXV:THCX) with a “Speculative Buy” rating and a one-year price target of $3.10, implying a return of 156.2 per cent at the time of publication.

Bottomley says a slide in shares of The Hydropothecary Corporation that began soon after its public listing presents an opportunity for investors, as the reason for the pullback is fleeting in nature.

“We believe the primary driver for the company’s reduced valuation relates to trace amounts of myclobutanil found on its product in early May,” the analyst notes. “In our view, this issue is transient in nature, was at a lower concentration level than other industry contaminations, and has been adequately dealt with by management; however, the company still trades at a ~58% discount to its 2017 highs compared to peers at (~30%).As a result, we would be buyers of Hydropothecary at current levels as we believe the company’s premium branding strategy and low-cost production should justify a multiple that is more in line with peers as the recent contamination issue is put further in the rear-view mirror while the company executes on a greenhouse expansion that we estimate could bring its total capacity to ~25,000 kg by the end of 2018.”

Bottomley thinks The Hydropothecary Corporation will generate Adjusted EBITDA of negative $3.6-million on revenue of $7.0-million in fiscal 2017. He expects those numbers will improve to EBITDA of positive $8.3-million on a topline of $30.0-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
insta twitter facebook


Leave a Reply